| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2972674 | The Journal of Heart and Lung Transplantation | 2008 | 8 Pages |
Abstract
Evidence for the use of induction therapy after heart transplantation is sparse. This systematic review found no convincing evidence of a survival benefit or reduction in cardiac allograft rejection. Thus, the routine use of IL-2Ra in cardiac transplantation remains unsupported.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christian H. MD, Finn MD, PhD, Christian MD, DMSc, Daniel A. MD, DMSc,